Article
Targeting PGLYRP1 promotes antitumor immunity while inhibiting autoimmune neuroinflammation - Nature Immunology
Rating:
0.0
Views:
46
Likes:
1
Library:
1
Co-inhibitory and checkpoint molecules suppress T cell function in the tumor microenvironment, thereby rendering T cells dysfunctional. Although immune checkpoint blockade is a successful treatment option for multiple human cancers, severe autoimmune-like adverse effects can limit its application.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value